Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Golding

Showing results (151-160 of 192) with videos related to

Pageof 20
Sort By:
British Journal of Cancer|August 17, 2016
Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancerGary Beale, Emma J Haagensen, Huw D Thomas, et al.
Journal of Medicinal Chemistry|August 9, 2022
Build-Couple-Transform: A Paradigm for Lead-like Library Synthesis with Scaffold DiversityMélanie Uguen, Gemma Davison, Lukas J Sprenger, et al.
Molecular Cancer Therapeutics|September 20, 2005
Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulationMarzia Pennati, Allyson J Campbell, Maria Curto, et al.
Journal of Medicinal Chemistry|November 24, 2005
Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approachIan R Hardcastle, Xiaoling Cockcroft, Nicola J Curtin, et al.
Chemical Biology & Drug Design|November 13, 2014
Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping ApproachAndrey Zaytsev, Barry Dodd, Matteo Magnani, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanineR J Griffin, C E Arris, C Bleasdale, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
DNA-dependent protein kinase (DNA-PK) inhibitors: structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domainKate M Clapham, Julia Bardos, M Raymond V Finlay, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitorsAlex W White, Nicola J Curtin, Brian W Eastman, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 25, 2014
Trifluoroacetic acid in 2,2,2-trifluoroethanol facilitates S(N)Ar reactions of heterocycles with arylaminesBenoit Carbain, Christopher R Coxon, Honorine Lebraud, et al.
Organic & Biomolecular Chemistry|November 12, 2013
Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocyclesHonorine Lebraud, Christopher R Coxon, Victoria S Archard, et al.
Pageof 20

Showing results (151-160 of 192) with videos related to

Sort By:
Pageof 20
British Journal of Cancer|August 17, 2016
Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancerGary Beale, Emma J Haagensen, Huw D Thomas, et al.
Journal of Medicinal Chemistry|August 9, 2022
Build-Couple-Transform: A Paradigm for Lead-like Library Synthesis with Scaffold DiversityMélanie Uguen, Gemma Davison, Lukas J Sprenger, et al.
Molecular Cancer Therapeutics|September 20, 2005
Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulationMarzia Pennati, Allyson J Campbell, Maria Curto, et al.
Journal of Medicinal Chemistry|November 24, 2005
Discovery of potent chromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK) using a small-molecule library approachIan R Hardcastle, Xiaoling Cockcroft, Nicola J Curtin, et al.
Chemical Biology & Drug Design|November 13, 2014
Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping ApproachAndrey Zaytsev, Barry Dodd, Matteo Magnani, et al.
Journal of Medicinal Chemistry|November 7, 2000
Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)guanines and potentiation of temozolomide cytotoxicity in vitro by O(6)-(1-cyclopentenylmethyl)guanineR J Griffin, C E Arris, C Bleasdale, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2011
DNA-dependent protein kinase (DNA-PK) inhibitors: structure-activity relationships for O-alkoxyphenylchromen-4-one probes of the ATP-binding domainKate M Clapham, Julia Bardos, M Raymond V Finlay, et al.
Bioorganic & Medicinal Chemistry Letters|April 28, 2004
Potentiation of cytotoxic drug activity in human tumour cell lines, by amine-substituted 2-arylbenzimidazole-4-carboxamide PARP-1 inhibitorsAlex W White, Nicola J Curtin, Brian W Eastman, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 25, 2014
Trifluoroacetic acid in 2,2,2-trifluoroethanol facilitates S(N)Ar reactions of heterocycles with arylaminesBenoit Carbain, Christopher R Coxon, Honorine Lebraud, et al.
Organic & Biomolecular Chemistry|November 12, 2013
Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocyclesHonorine Lebraud, Christopher R Coxon, Victoria S Archard, et al.
Pageof 20